Evidence map›Paper›PMID 27391404›Full record

ArticleAngewandte Chemie (International ed. in English)2016

DNA-Catalyzed Introduction of Azide at Tyrosine for Peptide Modification.

Puzhou Wang, Scott K Silverman

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Sequence-Dependent Acylation of Peptide Lysine Residues by DNAzymes.Chembiochem : a European journal of chemical biology · 2024
    Article
  3. DNAmoreDB, a database of DNAzymes.Nucleic acids research · 2021
    Article
  4. DNAzymes for amine and peptide lysine acylation.Organic & biomolecular chemistry · 2021
    Article
  5. Article
  6. Tyrosine bioconjugation - an emergent alternative.Organic & biomolecular chemistry · 2020
    Review
  7. DNA-Catalyzed Introduction of Azide at Tyrosine for Peptide Modification.Angewandte Chemie (International ed. in English) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Puzhou WangDepartment of Chemistry, University of Illinois at Urbana-Champaign, 600 South Mathews Avenue, Urbana, IL, 61801, USA.ORCID 0000-0001-6636-4892
Scott K SilvermanDepartment of Chemistry, University of Illinois at Urbana-Champaign, 600 South Mathews Avenue, Urbana, IL, 61801, USA. sks@illinois.edu.ORCID 0000-0001-8166-3460
University of Illinois Urbana-Champaign · US

Funding

Deoxyribozymes that ligate RNAR01GM065966 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI SILVERMAN, SCOTT K · 2003 to 2016
$4.2M
NIGMS NIH HHS R01 GM065966
6 · The paper itself

Abstract

We show that DNA enzymes (deoxyribozymes) can introduce azide functional groups at tyrosine residues in peptide substrates. Using in vitro selection, we identified deoxyribozymes that transfer the 2'-azido-2'-deoxyadenosine 5'-monophosphoryl group (2'-Az-dAMP) from the analogous 5'-triphosphate (2'-Az-dATP) onto the tyrosine hydroxyl group of a peptide, which is either tethered to a DNA anchor or free. Some of the new deoxyribozymes are general with regard to the amino acid residues surrounding the tyrosine, while other DNA enzymes are sequence-selective. We use one of the new deoxyribozymes to modify free peptide substrates by attaching PEG moieties and fluorescent labels.

Indexed as

AzidesBiocatalysisDNA, CatalyticMolecular ConformationPeptidesTyrosineAzidesDNA, CatalyticPeptidesTyrosinedeoxyribozymesDNAin vitro selectionpeptide modificationpeptides

Identifiers

PMID27391404
PMCPMC4993102
OpenAlexW2472462269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.